14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
TXN vs MCHPP: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Texas Instruments Incorporated (TXN) is the stronger overall head-to-head candidate over Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock (MCHPP) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). TXN carries a Unified Composite Score of 49.5/100 (HOLD) at $297.17 (26.2x Forward P/E, 41.1% operating margin), whereas MCHPP carries 57.1/100 (HOLD) at $52.64 (N/M Forward P/E, 21.6% operating margin).
Composite vs. Pillar Nuance: While MCHPP currently prints a higher short-term Unified Composite Score (57.1/100 HOLD vs. TXN 49.5/100 HOLD), TXN captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (41.1% vs. 21.6% operating margin) and revenue trajectory (+27.7% vs. +42.2% YoY).
Technical & Structure Timing Caution: TXN trades in a Markup technical trend (CONSOLIDATION options phase, RSI 51.1); meanwhile MCHPP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TXN vs MCHPP. Trailing 12-month operating profitability (TXN 41.1% vs MCHPP 21.6%) and valuation multiples (TXN 26.2x vs MCHPP N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Investor FAQ TXN vs MCHPP Key Questions & Quantitative Answers
As of Nov 16, 2026, Texas Instruments Incorporated (TXN) is the stronger overall head-to-head candidate over Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock (MCHPP) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). TXN carries a Unified Composite Score of 49.5/100 (HOLD) at $297.17 (26.2x Forward P/E, 41.1% operating margin), whereas MCHPP carries 57.1/100 (HOLD) at $52.64 (N/M Forward P/E, 21.6% operating margin). Composite vs. Pillar Nuance: While MCHPP currently prints a higher short-term Unified Composite Score (57.1/100 HOLD vs. TXN 49.5/100 HOLD), TXN captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (41.1% vs. 21.6% operating margin) and revenue trajectory (+27.7% vs. +42.2% YoY). Technical & Structure Timing Caution: TXN trades in a Markup technical trend (CONSOLIDATION options phase, RSI 51.1); meanwhile MCHPP is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
TXN leads the Growth & Scale pillar: TXN posts +27.7% YoY revenue growth and +77.0% YoY earnings growth on $20.8B TTM revenue (60.2% gross margin, 41.1% operating margin), compared with MCHPP at +42.2% YoY revenue growth and N/A YoY earnings growth on $5.60B TTM revenue (62.7% gross margin, 21.6% operating margin). On trailing 12-month operating scale, TXN generates $20.8B in USD-normalized revenue versus $5.60B for MCHPP. In operating R&D and SG&A reinvestment, TXN deploys 19.1% of Rev ($3.97B) (0 90-day corporate R&D disclosures) versus 41.1% of Rev ($2.30B) (0 disclosures) for MCHPP.
TXN screens cheaper on headline valuation multiples. TXN trades at 26.2x Forward P/E, 40.2x Trailing P/E, 0.94x PEG, and 14.2x EV/Revenue (35.2% FCF margin), whereas MCHPP trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (33.3% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against TXN (39.7% ROE) versus MCHPP (12.6% ROE) capital efficiency.
In options market volatility and institutional positioning, TXN carries 43.2% implied volatility (16th %ile, Compressed (<25th %ile)), a 0.92x (Balanced) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.82β · 57% Vol realized risk). By comparison, MCHPP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.16β · 65% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Microchip Technology Incorporated Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock (MCHPP) Research Suite
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.